In this presentation, Dr. Mera provides an overview of point-of-care HCV RNA testing and its role in enabling hepatitis C diagnosis and linkage to care within a single visit. He… […]
Keyword: hep c
Hepatitis C Elimination in Tribal Health: Expanding Access, Improving Outcomes, and Advancing Population Health | July 1, 2026
In this presentation, Dr. Brownell reviews current evidence-based approaches to hepatitis C screening, evaluation, treatment, and elimination within a tribal healthcare system. She highlights multidisciplinary strategies to expand access to care, the… […]
HCV Treatment Monitoring: Keeping it Simple | November 5, 2025
In this session, Dr. Paulina Deming discusses baseline laboratories recommended for HCV treatment evaluation, identifies patients eligible for simplified monitoring and shares HCV treatment monitoring recommendations. […]
Read More… from HCV Treatment Monitoring: Keeping it Simple | November 5, 2025
HCV in Pregnancy | December 4, 2024
In this presentation, Karla Thornton, MD, MPH, describes epidemiology of HCV in pregnancy, reviews the importance of testing for HCV in pregnancy, and describe early data in HCV treatment trial… […]
Use of HCV Antivirals in Patients with Swallowing Difficulties | November 6, 2024
In this presentation, Jessica Orizu, PharmD Candidate, will review the use of direct-acting antivirals (DAAs) in patients with swallowing difficulties, focusing on the use of sofosbuvir/velpatasvir (Epclusa) and glecaprevir/pibrentasvir (Mavyret).… […]
Read More… from Use of HCV Antivirals in Patients with Swallowing Difficulties | November 6, 2024
Common HCV DAA Drug Interactions | September 25, 2024
In this presentation, Dr. Brad Moran describes the interaction potential between DAA therapies and common medications. […]
Read More… from Common HCV DAA Drug Interactions | September 25, 2024
HCV Treatment Monitoring: Keeping it Simple | July 17, 2024
In this session, Dr. Paulina Deming discusses baseline laboratories recommended for HCV treatment evaluation, identifies patients eligible for simplified monitoring and shares HCV treatment monitoring recommendations. […]
Read More… from HCV Treatment Monitoring: Keeping it Simple | July 17, 2024
Medications for HCV in Pediatric Patients | March 6, 2024
In this presentation, Dr. Paulina Deming discusses the latest guidance on HCV screening in pediatrics, as well recommendations for monitoring and management. Then, Dr. Deming discusses the available HCV medications… […]
Read More… from Medications for HCV in Pediatric Patients | March 6, 2024
Long-Term Follow-Up After HCV Treatment | February 21, 2024
In this presentation, Dr. Paulina Deming discusses the needed follow-up for patients with and without cirrhosis who have completed HCV treatment. […]
Read More… from Long-Term Follow-Up After HCV Treatment | February 21, 2024
HCV Screening, Management and Treatment Guidelines | March 13, 2024
In this training, Dr. Paulina Deming, Dr. Karla Thornton, and Dr. Richard Manch discuss treatment and management of patients with hepatitis C in primary care, including medications, approaches to treatment,… […]
Read More… from HCV Screening, Management and Treatment Guidelines | March 13, 2024
